[ad_1]
This story originally appeared on Zacks
Amyris, Inc. (AMRS) closed at $4.59 in the latest trading session, marking a +1.1% move from the prior day. The stock outpaced the S&P 500’s daily loss of 0.41%. At the same time, the Dow lost 0.01%, and the tech-heavy Nasdaq gained 0.13%.
– Zacks
Prior to today’s trading, shares of the company had lost 26.3% over the past month. This has lagged the Basic Materials sector’s gain of 4.05% and the S&P 500’s gain of 2.36% in that time.
Investors will be hoping for strength from Amyris, Inc. as it approaches its next earnings release. On that day, Amyris, Inc. is projected to report earnings of -$0.20 per share, which would represent year-over-year growth of 54.55%. Meanwhile, our latest consensus estimate is calling for revenue of $64.1 million, down 19.61% from the prior-year quarter.
Any recent changes to analyst estimates for Amyris, Inc. should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company’s business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Amyris, Inc. currently has a Zacks Rank of #3 (Hold).
The Chemical – Specialty industry is part of the Basic Materials sector. This group has a Zacks Industry Rank of 163, putting it in the bottom 37% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
As one investor put it, “curing and preventing hundreds of diseases…what should that market be worth?” This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Amyris, Inc. (AMRS): Free Stock Analysis Report
To read this article on Zacks.com click here.
[ad_2]
Source link
